Home » Year in Review: The Best Trial Advice of 2012
Year in Review: The Best Trial Advice of 2012
January 2, 2013
Whether efforts to increase data sharing and transparency, tips on seeking expanded indications, how to negotiate payment for research-related injuries or the latest on adaptive trials, CTA has strived to keep readers abreast of the ever-changing regulatory and business landscape of clinical trials. This recap looks at the trends and topics that defined 2012 and offers a roadmap for ensuring success in 2013 and beyond.